Navigation Links
Primera Biosystems Raises $21 Million in Series B Private Round
Date:1/8/2008

MANSFIELD, Massachusetts, January 8 /PRNewswire/ -- Primera Biosystems, Inc., an emerging molecular diagnostics company with assay programs in infectious disease and oncology, announced today that it has closed on $21 million of Series B financing led by Abingworth and joined by Interwest Partners. Existing investors Malaysian Technology Development Corporation (MTDC), MPM Capital, Burrill & Company and the Invus Group also participated in the round.

"Primera plans to use this financing to complete development of our instrument system, reagent kits for disease-specific clinical research, future diagnostic tests as well as support ongoing research and development efforts," said Martin L. Verhoef, President and Chief Executive Officer of Primera Biosystems, Inc. "With help from our new and existing investors, we will stay ahead of the field by developing molecular diagnostics that have significant impact on patient management and deliver real benefits for doctors, patients and payers."

Primera is developing a proprietary nucleic acid analysis system, "STAR" (Scalable Target Amplification Routine), that combines in a single bench-top system the best features of quantitative real-time PCR with - true multiplexing of 60 or more targets. By increasing throughput and lowering costs -- while maintaining accuracy and quantification -- the STAR system has the potential to become the premier next generation real-time PCR platform for use in clinical development and diagnostics. The technology was invented by Vladimir Slepnev Ph.D., Primera's Chief Scientific Officer and co-founder. The technology can be applied for gene expression, DNA/RNA analysis, micro RNA analysis, mutation analysis and methylated DNA analysis. The Company's first test leveraging STAR is ViraQuant(TM), a market-ready assay for the simultaneous quantitative measurement of multiple viral agents that cause infections in immune compromised patients. A multiplex fungal test will follow. The
'/>"/>

SOURCE Primera Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
3. Pearl Therapeutics Raises $15.5 Million in Private Financing
4. Enobia Pharma Raises $40.1 Million Series B Financing
5. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
6. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
7. VisEn Medical Raises $7 Million in Series B Financing
8. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
9. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
10. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
11. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... COLUMBUS, Ohio, Nov. 30 The Ohio ... of the nation,s first minority business early-sta...eland December 3, is called "Transforming the Land...Early-Stage Capital Summit." It will feature sever... business leaders and local minority entrepreneurs...
(Date:11/30/2009)... NEW YORK, Nov. 30 The ... (MJFF) today announced $1.5 million in total awar...ially disease-modifying therapies for Parkinson,s ...Approaches to Drug Discovery for Parkinson,s Disea...rporation, plc (NYSE: ELN ), a neuroscience-base...
(Date:11/30/2009)...HICAGO, Nov. 30 Dr. Jessica Torren...hington University Medical Center in Washington, D...t-Specific Gamma Imaging (BSGI) in clinical practi...s of breast cancer today at the annual meeting of ...,, "The purpose of the exhibit was to demonstra...
(Date:11/30/2009)... PDS, a leader in providing smart and...announces Pajama Pathology®, evolutionizing wo...‘gold standard’ software used by 8 of ...but on a ‘cost per slide’ basis. , ...November 30, 2009 -- PDS has announced another evo...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
...Inc. (OTC Bulletin Board: TBIO) is canceling the f...omic Inc. Fourth Quarter 2008 Earnings Release, ...nesday, February 25, 2009 @ 5:00 p.m. Eastern, ... , , , Transgenomic will communicate by Press R...r the Fourth Quarter 2008 Earnings Release Confere...
...ioidentical hormones are superior to synthetic HRT...risk of breast cancer , , TORRANCE, Calif., Feb. ...shed in the Postgraduate Medical Journal, a leadin...ans, showed that bioidentical hormones are associa...ious than their synthetic counterparts. Conducted ...
...GeneraMedix, Inc. announced,today that it has ente...ed,formulation of epoprostenol sodium for the intr...on (PAH) to Actelion LTD., a biopharmaceutical com...tzerland. Financial terms of the deal,were not dis...mpany,s ongoing commitment to serving,the unique n...
Other Biology Technology:New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 2New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 3GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 2GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd. 3
(Date:12/1/2009)...d international research team has developed an inn...tion of solar cells. , Scientists at Monash Univ...universities of Wollongong and Ulm in Germany, hav...a three-fold increase in energy conversion efficie...ensitised solar cells. , Lead researcher Dr Udo...
(Date:12/1/2009)...among groups of people, research at the University...o and Harvard shows., Using longitudinal data fr...lth conditions for more than 60 years, a team of s...ir loneliness with others. Gradually over time, a ...fringes of social networks., We detected an extr...
(Date:11/30/2009)...s Ron Falta and Larry Murdoch have received an $89...dy the safe storage of carbon dioxide in geologica...e. , With carbon dioxide emissions from burning ...lobal warming, geologic storage of the gas is one ...issions using current technology. , "Geologic st...
Breaking Biology News(10 mins):Innovation puts next-generation solar cells on the horizon 2Loneliness can be contagious 2Loneliness can be contagious 3China Sky One Medical Inc Appoints New Independent Director 13412 1China Sky One Medical Inc Appoints New Independent Director 13412 2China Sky One Medical Inc Appoints New Independent Director 13412 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 1CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 2
...west National Laboratory scientists have used elec...molecules lasagna-like around spaghetti-like carbo... a wide range of applications, from ultra-precise ...on, said Yuehe Lin, who led the research at the De...l Molecular Sciences Laboratory. , The technique...
...Riverside have discovered a molecular mechanism di...al development. The findings could hold promise fo.... , The research is published in the Feb. 24 edit...ssor Frank Sauer, with German colleague Elisabeth ... in Munich, and fellow UCR researchers Tilman Sanc...
...er to survey the entire human genome and identify ...lex diseases, researchers at Johns Hopkins, togeth...ramingham Heart Study, U.S.A., have identified a g...art rhythms that lead to sudden cardiac death, a c...s each year. , The gene called NOS1AP, not previo...
Other Biology News:A biosensor layered like lasagna 2Researchers unlock how cells determine their functions 2Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm 2Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm 3
Experion Pro260 Reagents and Supplies, for 10 chips from Bio-Rad
...Staccato Mini-Workstations provide fast and reliab..., proteomics and drug development laboratories. St...of instrumentation to automate basic liquid handli...rkstations are controlled with either Caliper's ti...
Aldehyde Slides from Genetix
...The Experion system, 100-120 and 220-240 V, is a m...eps of gel-based electrophoresis, including some d...tion is used for protein analysis (it does not inc.... The system includes the electrophoresis station,...
Biology Products: